fashion -WSS

fashion

author：hotspot 2025-09-06 04:51:35 - browse：7

a stethoscope and money – hospitals and health insurance coverage from STAT — Bright Health is officially leaving the health insurance market. The company has agreed to sell its Medicare Advantage plans to Molina Healthcare. Adobe

Bright Health Group has agreed to sell its Medicare Advantage plans to its publicly traded peer Molina Healthcare.

Regulators must approve the deal. But the pending sale of its Medicare Advantage business means the financially distressed Bright has exited the health insurance market that the company was founded on. It will solely operate roughly 70 physician clinics located in California, Texas, and Florida.

Molina agreed to pay $600 million for Bright’s 125,000 California Medicare Advantage enrollees, which equates to about $4,800 for each person. The federal government paid insurance companies almost $12,000, on average, for each MA enrollee in 2022. Molina said in a news release that Bright’s current book of business generates $1.8 billion of revenue, or more than $14,000 for each member.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Four alarming medical procedures we’re glad history forgot

WSS

Insurer loopholes limit power of law against surprise medical bills

Obesity drugs seen as possible treatment for liver disease MASH

People with mental disorders often marry others with same

Young boy dies in trial for Pfizer Duchenne gene therapy

UnitedHealth, in a surprise, takes aim at Steward’s physician group

Ed Silverman on new gene therapies, biosimilars, coffee, and more

hotspot

fashion

entertainment

Sports medicine is finally prioritizing gender equality

Medicare Advantage 2025 payments will dip, Biden administration says

Hepatitis C has a cure — but many Americans still lack access to it

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

Supreme Court strikes down use of affirmative action

Readout Newsletter: Alnylam, Celldex, Roche, Zealand Pharma

Medical records are filled with copy

A solution to the after

After affirmative action ruling, medical educators look to 'holistic review'

STAT readers on older presidents, polypills, Medicare, and more

focus

Researchers test human milk's ability to repair gut microbiome

Dario to buy mental health app maker Twill in cash and stock deal

Why palliative psychiatry is worth discussing

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

He's a Nobel laureate. Critics say he was misleading on Covid

explore

focus

Wikipedia

knowledge